4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-061334
Chief Medical Officer sold 17,500 shares at an average $18.45 ($322,834)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2018-12-03 | Sale | −17,100 | $18.43 | $315,170 | 148,790 | I |
| Ho Carole Chief Medical Officer | 2018-12-03 | Sale | −400 | $19.16 | $7,664 | 148,390 | I |
| Open-market sales · 17,500 sh · avg $18.45 · $322,834 | |||||||
Loading xslF345X03/doc4.xml…